Boundless Bio to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

SAN DIEGO--()--Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Chief Executive Officer, Zachary Hornby, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021, from 1:20-1:50 p.m. ET.

About Boundless Bio

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

For more information, visit www.boundlessbio.com.

Follow us on LinkedIn and Twitter.

Contacts

James Lee
Director of Business Development
Boundless Bio
jlee@boundlessbio.com

Contacts

James Lee
Director of Business Development
Boundless Bio
jlee@boundlessbio.com